Cheng Jin1, Guohong Li1, Kathryn M Rexrode1, Mahmut E Gurol1, Xiaodong Yuan1, Ying Hui1, Chunyu Ruan1, Anand Vaidya1, Yanxiu Wang1, Shouling Wu2, Xiang Gao2. 1. From the Department of Cardiology (C.J., C.R., Y.W., S.W.), Department of Neurology (X.Y.), and Department of Medical Imaging (Y.H.), Kailuan General Hospital, Tangshan, China; Department of Nutritional Sciences, State College, Pennsylvania State University, University Park (C.J., X.G.); School of Public Health, Shanghai Jiao Tong University School of Medicine, China (G.L.); Division of Preventive Medicine (K.R.) and Division of Endocrinology, Diabetes, and Hypertension (A.V.), Brigham and Women's Hospital, Boston, MA; and Hemorrhagic Stroke Research Program, Massachusetts General Hospital, Harvard Medical School, Boston (M.E.G.). 2. From the Department of Cardiology (C.J., C.R., Y.W., S.W.), Department of Neurology (X.Y.), and Department of Medical Imaging (Y.H.), Kailuan General Hospital, Tangshan, China; Department of Nutritional Sciences, State College, Pennsylvania State University, University Park (C.J., X.G.); School of Public Health, Shanghai Jiao Tong University School of Medicine, China (G.L.); Division of Preventive Medicine (K.R.) and Division of Endocrinology, Diabetes, and Hypertension (A.V.), Brigham and Women's Hospital, Boston, MA; and Hemorrhagic Stroke Research Program, Massachusetts General Hospital, Harvard Medical School, Boston (M.E.G.). xxg14@psu.edu drwusl@163.com.
Abstract
BACKGROUND AND PURPOSE: Although diabetes mellitus is an established independent risk factor for ischemic stroke, the association between fasting blood glucose and intracerebral hemorrhage (ICH) is limited and inconsistent. The objective of the current study was to examine the potential impact of long-term fasting blood glucose concentration on subsequent risk of ICH. METHODS: This prospective study included 96 110 participants of the Kailuan study, living in Kailuan community, Tangshan city, China, who were free of cardiovascular diseases and cancer at baseline (2006). Fasting blood glucose concentration was measured in 2006, 2008, 2010, and 2012. Updated cumulative average fasting blood glucose concentration was used as primary exposure of the current study. Incident ICH from 2006 to 2015 was confirmed by review of medical records. RESULTS: During 817 531 person-years of follow-up, we identified 755 incident ICH cases. The nadir risk of ICH was observed at fasting blood glucose concentration of 5.3 mmol/L. The adjusted hazard ratios and their 95% confidence intervals (CIs) of ICH were 1.59 (95% CI, 1.26-2.02) for diabetes mellitus or fasting blood glucose ≥7.00 mmol/L, 1.31 (95% CI, 1.02-1.69) for impaired fasting blood glucose (fasting blood glucose, 6.10-6.99 mmol/L), 0.98 (95% CI, 0.78-1.22) for fasting blood glucose 5.60 to 6.09 mmol/L, and 2.04 (95% CI, 1.23-3.38) for hypoglycemia (fasting blood glucose, <4.00 mmol/L), comparing with normal fasting blood glucose 4.00 to 5.59 mmol/L. The results persisted after excluding individuals who used hypoglycemic, aspirin, antihypertensive agents, or anticoagulants, and those with intracerebral hemorrhagic cases occurred in the first 2 years of follow-up. CONCLUSIONS: In this large community-based cohort, low (<4.0 mmol/L) and high (≥6.1 mmol/L) fasting blood glucose concentrations were associated with higher risk of incident ICH, relative to fasting blood glucose concentrations of 4.00 to 6.09 mmol/L.
BACKGROUND AND PURPOSE: Although diabetes mellitus is an established independent risk factor for ischemic stroke, the association between fasting blood glucose and intracerebral hemorrhage (ICH) is limited and inconsistent. The objective of the current study was to examine the potential impact of long-term fasting blood glucose concentration on subsequent risk of ICH. METHODS: This prospective study included 96 110 participants of the Kailuan study, living in Kailuan community, Tangshan city, China, who were free of cardiovascular diseases and cancer at baseline (2006). Fasting blood glucose concentration was measured in 2006, 2008, 2010, and 2012. Updated cumulative average fasting blood glucose concentration was used as primary exposure of the current study. Incident ICH from 2006 to 2015 was confirmed by review of medical records. RESULTS: During 817 531 person-years of follow-up, we identified 755 incident ICH cases. The nadir risk of ICH was observed at fasting blood glucose concentration of 5.3 mmol/L. The adjusted hazard ratios and their 95% confidence intervals (CIs) of ICH were 1.59 (95% CI, 1.26-2.02) for diabetes mellitus or fasting blood glucose ≥7.00 mmol/L, 1.31 (95% CI, 1.02-1.69) for impaired fasting blood glucose (fasting blood glucose, 6.10-6.99 mmol/L), 0.98 (95% CI, 0.78-1.22) for fasting blood glucose 5.60 to 6.09 mmol/L, and 2.04 (95% CI, 1.23-3.38) for hypoglycemia (fasting blood glucose, <4.00 mmol/L), comparing with normal fasting blood glucose 4.00 to 5.59 mmol/L. The results persisted after excluding individuals who used hypoglycemic, aspirin, antihypertensive agents, or anticoagulants, and those with intracerebral hemorrhagic cases occurred in the first 2 years of follow-up. CONCLUSIONS: In this large community-based cohort, low (<4.0 mmol/L) and high (≥6.1 mmol/L) fasting blood glucose concentrations were associated with higher risk of incident ICH, relative to fasting blood glucose concentrations of 4.00 to 6.09 mmol/L.
Authors: N Sarwar; P Gao; S R Kondapally Seshasai; R Gobin; S Kaptoge; E Di Angelantonio; E Ingelsson; D A Lawlor; E Selvin; M Stampfer; C D A Stehouwer; S Lewington; L Pennells; A Thompson; N Sattar; I R White; K K Ray; J Danesh Journal: Lancet Date: 2010-06-26 Impact factor: 202.731
Authors: Valery L Feigin; George A Mensah; Bo Norrving; Christopher J L Murray; Gregory A Roth Journal: Neuroepidemiology Date: 2015-10-28 Impact factor: 3.282
Authors: Chanshin Park; Eliseo Guallar; John A Linton; Duk-Chul Lee; Yangsoo Jang; Dong Koog Son; Eun-Jeong Han; Soo Jin Baek; Young Duk Yun; Sun Ha Jee; Jonathan M Samet Journal: Diabetes Care Date: 2013-02-12 Impact factor: 19.112
Authors: Elizabeth R Seaquist; John Anderson; Belinda Childs; Philip Cryer; Samuel Dagogo-Jack; Lisa Fish; Simon R Heller; Henry Rodriguez; James Rosenzweig; Robert Vigersky Journal: Diabetes Care Date: 2013-04-15 Impact factor: 19.112
Authors: Sudeepta Dandapat; Fazeel M Siddiqui; Gregg C Fonarow; Deepak L Bhatt; Haolin Xu; Roland Matsouaka; Paul A Heidenreich; Ying Xian; Lee H Schwamm; Eric E Smith Journal: Heliyon Date: 2019-05-06
Authors: Duncan Wilson; Gareth Ambler; Clare Shakeshaft; Martin M Brown; Andreas Charidimou; Rustam Al-Shahi Salman; Gregory Y H Lip; Hannah Cohen; Gargi Banerjee; Henry Houlden; Mark J White; Tarek A Yousry; Kirsty Harkness; Enrico Flossmann; Nigel Smyth; Louise J Shaw; Elizabeth Warburton; Keith W Muir; Hans Rolf Jäger; David J Werring Journal: Lancet Neurol Date: 2018-05-16 Impact factor: 59.935